Independent Solutions Wealth Management LLC Decreases Stock Position in Chemed Co. (NYSE:CHE)

Independent Solutions Wealth Management LLC trimmed its position in shares of Chemed Co. (NYSE:CHE) by 3.6% in the 3rd quarter, Holdings Channel reports. The firm owned 536 shares of the company’s stock after selling 20 shares during the period. Independent Solutions Wealth Management LLC’s holdings in Chemed were worth $322,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. American National Bank & Trust purchased a new stake in shares of Chemed during the third quarter worth $61,000. GAMMA Investing LLC grew its stake in Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after acquiring an additional 52 shares in the last quarter. Quarry LP lifted its stake in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares in the last quarter. Sound Income Strategies LLC acquired a new position in shares of Chemed during the 3rd quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC grew its position in shares of Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after purchasing an additional 324 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CHE has been the topic of a number of recent research reports. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Chemed Stock Performance

CHE stock opened at $521.79 on Friday. Chemed Co. has a one year low of $516.91 and a one year high of $654.62. The firm has a market cap of $7.85 billion, a PE ratio of 26.37, a PEG ratio of 2.32 and a beta of 0.46. The firm’s 50 day moving average price is $565.72 and its 200-day moving average price is $564.07.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $5.32 EPS. Equities research analysts predict that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,132 shares of company stock worth $3,003,502 over the last three months. Insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.